These results, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the principle of concentrating on ACKR3 as a singular method to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Diseases.Could assist decrease nerve pain and